drugset / Trial / NCT00092729
An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).
Timeline
- Start
- 2002-06-07
- Primary completion
- 2002-12-06
- Completion
- 2002-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etoricoxib | Small molecule | 120 mg | — |
| Comparator | Naproxen | Small molecule | 550 mg | — |